Company profilePharmaceutical#243 of 1,318 in Pakistan✓ No DRAP alerts

DERMA TECHNO PAKISTAN

Pharmaceutical company · 76 brands · 64 molecules

Ranked #7 of 58 companies in Skin Conditions

76 registered products 35 pharmaceutical brands 64 distinct molecules 0 DRAP alerts

Company overview

76
registered products
35
pharmaceutical brands
64
distinct molecules
12
therapeutic classes
0
DRAP alerts

DERMA TECHNO PAKISTAN is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 76 product registrations across 64 distinct molecules. Its portfolio is concentrated in Skin Conditions and Corticosteroid, Plain. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by DERMA

15 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Acne Preparations 2

Top molecules by brand count

Lactic Acid3 brands
Hydroquinone3 brands
Isotretinoin3 brands
Terbinafine2 brands
Esomeprazole2 brands
Clobetasol2 brands
Fluconazole2 brands

Therapeutic classes

Skin Conditions · 8Corticosteroid, Plain · 7Corticosteroid Combinations, Topical · 6Anti-Acne Preparations · 5Antifungal For Dermatological · 4Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Antimycotics Systemic Use · 4Other Dermatological Preparations · 4Antihistamines For Systemic Use · 3Quinolone Antibacterials · 2Macrolides, Lincosamides And Streptogramins · 2Antibiotics For Topical Use · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 2Acne/Topical · 2Hyperpigmentation · 2Warts · 1Nappy Rash · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO5 products · Rs 69.35 – Rs 804
Servaid10 products · Rs 181.5 – Rs 473
Median across source: Rs 275.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.30 shared molecules
VALOR PHARMACEUTICALS30 shared molecules
SHROOQ PHARMACEUTICALS27 shared molecules
PEARL PHARMACEUTICALS23 shared molecules
NEUTRO PHARMA (PVT) LTD.22 shared molecules
Albro Pharmaceuticals21 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
VALOR PHARMACEUTICALS holds 155 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene
SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac

Get the full profile for DERMA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.